Literature DB >> 29203481

Concentrations of Cefuroxime in Brain Tissue of Neurointensive Care Patients.

A Hosmann1, L C Ritscher1, H Burgmann2, Z Oesterreicher3, W Jäger4, S Poschner4, E Knosp1, A Reinprecht1, A Gruber1,5, M Zeitlinger6.   

Abstract

Effective concentrations of antibiotics in brain tissue are essential for antimicrobial therapy of brain infections. However, data concerning cerebral penetration properties of antibiotics for treatment or prophylaxis of central nervous system infections are rare. Six patients suffering subarachnoid hemorrhage and requiring cerebral microdialysis for neurochemical monitoring were included in this study. Free interstitial concentrations of cefuroxime after intravenous application of 1,500 mg were measured by microdialysis in brain tissue, as well as in plasma at steady-state (n = 6) or after single-dose administration (n = 1). At steady state, free area under the concentration-time curve from 0 to 24 h (AUC0-24) values of 389.0 ± 210.3 mg/liter·h and 131.4 ± 72.8 mg/liter·h were achieved for plasma and brain, respectively, resulting in a brain tissue penetration ratio (AUC0-24 brain/AUC0-24 free plasma) of 0.33 ± 0.1. Plasma and brain tissue concentrations at individual time points correlated well (R = 0.59, P = 0.001). At steady-state time over MIC (t>MIC) values of >40% of dosing interval were achieved up to an MIC of 16 mg/liter for plasma and 4 mg/liter for brain tissue. Although MIC90 values could not be achieved in brain tissue for relevant bacteria, current dosing strategies of cefuroxime might be sufficient to treat pathogens with MIC values up to 4 mg/liter. The activity of cefuroxime in brain tissue might be overestimated when relying exclusively on plasma levels. Although currently insufficient data after single dose administration exist, lower brain-plasma ratios observed after the first dose might warrant a loading dose for treatment and perioperative prophylaxis.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  brain; cefuroxime; central nervous system infections; drug tissue concentration; in vivo pharmacokinetics; microdialysis

Mesh:

Substances:

Year:  2018        PMID: 29203481      PMCID: PMC5786752          DOI: 10.1128/AAC.02164-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Simultaneous measurement of cefuroxime in rat blood and brain by microdialysis and microbore liquid chromatography. Application to pharmacokinetics.

Authors:  T H Tsai; F C Cheng; K C Chen; Y F Chen; C F Chen
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-11-26

2.  Levels of vancomycin in the cerebral interstitial fluid after severe head injury.

Authors:  Anselmo Caricato; Mariano Pennisi; Aldo Mancino; Gianluca Vigna; Claudio Sandroni; Andrea Arcangeli; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

3.  International and specialty trends in the use of prophylactic antibiotics to prevent infectious complications after insertion of external ventricular drainage devices.

Authors:  Paul J McCarthy; Shashikant Patil; Steven A Conrad; L Keith Scott
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

Review 4.  Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice.

Authors:  Matthew J Labreche; Christopher J Graber; Hien M Nguyen
Journal:  Clin Infect Dis       Date:  2015-06-23       Impact factor: 9.079

Review 5.  Current practice of external ventricular drainage: a survey among neurosurgical departments in Germany.

Authors:  Zafer Cinibulak; Alfred Aschoff; Anani Apedjinou; Jan Kaminsky; Hans A Trost; Joachim K Krauss
Journal:  Acta Neurochir (Wien)       Date:  2016-03-01       Impact factor: 2.216

6.  Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Sang-Bae Ko; Raimund Helbok; Pedro Kurtz; R Morgan Stuart; Mary Presciutti; Luis Fernandez; Kiwon Lee; Neeraj Badjatia; E Sander Connolly; Jan Claassen; Stephan A Mayer
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

7.  External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study.

Authors:  Giuseppe Citerio; Liana Signorini; Alfio Bronco; Alessia Vargiolu; Matteo Rota; Nicola Latronico
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

8.  Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.

Authors:  D J Hoban; S K Bouchillon; J L Johnson; G G Zhanel; D L Butler; K A Saunders; L A Miller; J A Poupard
Journal:  Int J Antimicrob Agents       Date:  2003-05       Impact factor: 5.283

9.  Ventriculostomy-related infections: a critical review of the literature.

Authors:  Alan P Lozier; Robert R Sciacca; Mario F Romagnoli; E Sander Connolly
Journal:  Neurosurgery       Date:  2008-02       Impact factor: 4.654

Review 10.  Nosocomial ventriculitis and meningitis in neurocritical care patients.

Authors:  R Beer; P Lackner; B Pfausler; E Schmutzhard
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

View more
  3 in total

1.  Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section.

Authors:  Hanadi H Alrammaal; Khaled Abduljalil; Victoria Hodgetts Morton; R Katie Morris; John F Marriott; Hsu P Chong; Hannah K Batchelor
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

2.  Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin.

Authors:  Zoe Oesterreicher; Sabine Eberl; Beatrix Wulkersdorfer; Peter Matzneller; Claudia Eder; Esther van Duijn; Wouter H J Vaes; Birgit Reiter; Thomas Stimpfl; Walter Jäger; Alina Nussbaumer-Proell; Daniela Marhofer; Peter Marhofer; Oliver Langer; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2022-01-07       Impact factor: 5.577

3.  Isolation, identification and reviewing the health effect of HPC bacteria in household point-of-use (PoU) water treatment devices: a case study, Ahvaz, Iran.

Authors:  Nastaran Talepour; Mahdi Hadi; Simin Nasseri; Neamat Jaafarzadeh Haghighi Fard; Alireza Mesdaghinia; Saeedeh Hemmati Borji
Journal:  J Environ Health Sci Eng       Date:  2021-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.